Oruka Net Receivables from 2010 to 2026
| ORKA Stock | 26.40 1.41 5.07% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 529.2 K | Current Value 502.7 K | Quarterly Volatility 154.2 K |
Check Oruka Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oruka Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 23.1 K, Interest Expense of 1.4 M or Total Revenue of 56.6 M, as well as many indicators such as Price To Sales Ratio of 2.28, Dividend Yield of 0.8 or PTB Ratio of 0.73. Oruka financial statements analysis is a perfect complement when working with Oruka Therapeutics Valuation or Volatility modules.
Oruka | Net Receivables | Build AI portfolio with Oruka Stock |
Latest Oruka Therapeutics' Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Oruka Therapeutics over the last few years. It is Oruka Therapeutics' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oruka Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Oruka Net Receivables Regression Statistics
| Arithmetic Mean | 615,938 | |
| Geometric Mean | 604,027 | |
| Coefficient Of Variation | 25.04 | |
| Mean Deviation | 69,537 | |
| Median | 588,000 | |
| Standard Deviation | 154,236 | |
| Sample Variance | 23.8B | |
| Range | 704.3K | |
| R-Value | (0.49) | |
| Mean Square Error | 19.4B | |
| R-Squared | 0.24 | |
| Significance | 0.05 | |
| Slope | (14,818) | |
| Total Sum of Squares | 380.6B |
Oruka Net Receivables History
About Oruka Therapeutics Financial Statements
Oruka Therapeutics stakeholders use historical fundamental indicators, such as Oruka Therapeutics' Net Receivables, to determine how well the company is positioned to perform in the future. Although Oruka Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Oruka Therapeutics' assets and liabilities are reflected in the revenues and expenses on Oruka Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Oruka Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 529.2 K | 502.7 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Oruka Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oruka Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oruka Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oruka Therapeutics Stock:Check out the analysis of Oruka Therapeutics Correlation against competitors. For information on how to trade Oruka Stock refer to our How to Trade Oruka Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oruka Therapeutics. If investors know Oruka will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oruka Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oruka Therapeutics is measured differently than its book value, which is the value of Oruka that is recorded on the company's balance sheet. Investors also form their own opinion of Oruka Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Oruka Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oruka Therapeutics' market value can be influenced by many factors that don't directly affect Oruka Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oruka Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oruka Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oruka Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.